BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 25794851)

  • 1. Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.
    Lin Z; Pan X; Wu F; Ye D; Zhang Y; Wang Y; Jin L; Lian Q; Huang Y; Ding H; Triggle C; Wang K; Li X; Xu A
    Circulation; 2015 May; 131(21):1861-71. PubMed ID: 25794851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast Growth Factor 21 Protects against Atherosclerosis via Fine-Tuning the Multiorgan Crosstalk.
    Jin L; Lin Z; Xu A
    Diabetes Metab J; 2016 Feb; 40(1):22-31. PubMed ID: 26912152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model.
    Maeng HJ; Lee GY; Bae JH; Lim S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect of dichloroacetate against atherosclerosis via hepatic FGF21 induction mediated by acute AMPK activation.
    Min BK; Oh CJ; Park S; Lee JM; Go Y; Park BY; Kang HJ; Kim DW; Kim JE; Yoo EK; Kim HE; Kim MJ; Jeon YH; Kim YH; Lee CH; Jeon JH; Lee IK
    Exp Mol Med; 2019 Sep; 51(10):1-12. PubMed ID: 31570705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
    Ye D; Wang Y; Li H; Jia W; Man K; Lo CM; Wang Y; Lam KS; Xu A
    Hepatology; 2014 Sep; 60(3):977-89. PubMed ID: 24590984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perhexiline activates KLF14 and reduces atherosclerosis by modulating ApoA-I production.
    Guo Y; Fan Y; Zhang J; Lomberk GA; Zhou Z; Sun L; Mathison AJ; Garcia-Barrio MT; Zhang J; Zeng L; Li L; Pennathur S; Willer CJ; Rader DJ; Urrutia R; Chen YE
    J Clin Invest; 2015 Oct; 125(10):3819-30. PubMed ID: 26368306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice.
    Lin Z; Tian H; Lam KS; Lin S; Hoo RC; Konishi M; Itoh N; Wang Y; Bornstein SR; Xu A; Li X
    Cell Metab; 2013 May; 17(5):779-89. PubMed ID: 23663741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 21 inhibits atherosclerosis in apoE-/- mice by ameliorating Fas-mediated apoptosis.
    Yan X; Gou Z; Li Y; Wang Y; Zhu J; Xu G; Zhang Q
    Lipids Health Dis; 2018 Aug; 17(1):203. PubMed ID: 30157856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice.
    Guo Q; Xu L; Liu J; Li H; Sun H; Wu S; Zhou B
    Exp Biol Med (Maywood); 2017 Feb; 242(4):441-447. PubMed ID: 27811171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment with FGF21 strongly improves plasma cholesterol metabolism to reduce atherosclerosis.
    Liu C; Schönke M; Zhou E; Li Z; Kooijman S; Boon MR; Larsson M; Wallenius K; Dekker N; Barlind L; Peng XR; Wang Y; Rensen PCN
    Cardiovasc Res; 2022 Jan; 118(2):489-502. PubMed ID: 33693480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of fibroblast growth factor 21 in atherosclerosis.
    Kokkinos J; Tang S; Rye KA; Ong KL
    Atherosclerosis; 2017 Feb; 257():259-265. PubMed ID: 28012645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 21 improves insulin resistance and ameliorates renal injury in db/db mice.
    Kim HW; Lee JE; Cha JJ; Hyun YY; Kim JE; Lee MH; Song HK; Nam DH; Han JY; Han SY; Han KH; Kang YS; Cha DR
    Endocrinology; 2013 Sep; 154(9):3366-76. PubMed ID: 23825123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The moderate essential amino acid restriction entailed by low-protein vegan diets may promote vascular health by stimulating FGF21 secretion.
    McCarty MF
    Horm Mol Biol Clin Investig; 2016 Feb; 30(1):. PubMed ID: 26872317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting.
    Liang Q; Zhong L; Zhang J; Wang Y; Bornstein SR; Triggle CR; Ding H; Lam KS; Xu A
    Diabetes; 2014 Dec; 63(12):4064-75. PubMed ID: 25024372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
    Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
    Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid increase in fibroblast growth factor 21 in protein malnutrition and its impact on growth and lipid metabolism.
    Ozaki Y; Saito K; Nakazawa K; Konishi M; Itoh N; Hakuno F; Takahashi S; Kato H; Takenaka A
    Br J Nutr; 2015 Nov; 114(9):1410-8. PubMed ID: 26330054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast growth factor 21 potentially inhibits microRNA-33 expression to affect macrophage actions.
    Guo Y; Luo F; Yi Y; Xu D
    Lipids Health Dis; 2016 Dec; 15(1):208. PubMed ID: 27905947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
    Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
    Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF21 Prevents Angiotensin II-Induced Hypertension and Vascular Dysfunction by Activation of ACE2/Angiotensin-(1-7) Axis in Mice.
    Pan X; Shao Y; Wu F; Wang Y; Xiong R; Zheng J; Tian H; Wang B; Wang Y; Zhang Y; Han Z; Qu A; Xu H; Lu A; Yang T; Li X; Xu A; Du J; Lin Z
    Cell Metab; 2018 Jun; 27(6):1323-1337.e5. PubMed ID: 29706566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.